CC BY 4.0 · Rev Bras Ginecol Obstet 2023; 45(06): 303-311
DOI: 10.1055/s-0043-1770087
Original Article
High Risk Pregnancy

Impact of Obesity and Hyperglycemia on Pregnancy-specific Urinary Incontinence

Impacto da obesidade e hiperglicemia na incontinência urinária específica da gravidez
1   Perinatal Diabetes Research Center, Botucatu Medical School, Universidade Estadual Paulista, Botucatu, SP, Brazil
,
1   Perinatal Diabetes Research Center, Botucatu Medical School, Universidade Estadual Paulista, Botucatu, SP, Brazil
,
1   Perinatal Diabetes Research Center, Botucatu Medical School, Universidade Estadual Paulista, Botucatu, SP, Brazil
2   Department of Health Sciences, Universidade Sagrado Coração, Bauru, São Paulo, Brazil
,
1   Perinatal Diabetes Research Center, Botucatu Medical School, Universidade Estadual Paulista, Botucatu, SP, Brazil
,
1   Perinatal Diabetes Research Center, Botucatu Medical School, Universidade Estadual Paulista, Botucatu, SP, Brazil
3   Department of Biostatistics, Bioscience Institute, Universidade Estadual Paulista, Botucatu, SP, Brazil
,
1   Perinatal Diabetes Research Center, Botucatu Medical School, Universidade Estadual Paulista, Botucatu, SP, Brazil
› Author Affiliations

Abstract

Objective The lack of data on the impact of hyperglycemia and obesity on the prevalence of pregnancy-specific urinary incontinence (PSUI) led us to conduct a cross-sectional study on the prevalence and characteristics of PSUI using validated questionnaires and clinical data.

Methods This cross-sectional study included 539 women with a gestational age of 34 weeks who visited a tertiary university hospital between 2015 and 2018. The main outcome measures were the prevalence of PSUI, the International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), and the Incontinence Severity Index (ISI) questionnaires. The women were classified into four groups: normoglycemic lean, normoglycemic obese, hyperglycemic lean, and hyperglycemic obese. The differences between groups were tested using descriptive statistics. Associations were estimated using logistic regression analysis and presented as unadjusted and adjusted odds ratios.

Results Prevalence rates of PSUI were no different between groups. However, significant difference in hyperglycemic groups worse scores for severe and very severe PSUI. When adjusted data for confound factors was compared with normoglycemic lean group, the hyperglycemic obese group had significantly higher odds for severe and very severe forms of UI using ICIQ-SF (aOR 3.157; 95% CI 1.308 to 7.263) and ISI (aOR 20.324; 95% CI 2.265 to 182.329) questionnaires and highest perceived impact of PSUI (aOR 4.449; 95% CI 1.591 to 12.442).

Conclusion Our data indicate that obesity and hyperglycemia during pregnancy significantly increase the odds of severe forms and perceived impact of PSUI. Therefore, further effective preventive and curative treatments are greatly needed.

Resumo

Objetivo A falta de dados sobre o impacto da hiperglicemia e obesidade na prevalência de incontinência urinária específica da gravidez (IAPS) nos levou a realizar um estudo transversal sobre a prevalência e características da IAPS usando questionários validados e dados clínicos.

Métodos Este estudo transversal incluiu 539 mulheres com idade gestacional de 34 semanas que visitaram um hospital universitário terciário entre 2015 e 2018. As principais medidas de desfecho foram a prevalência de PSUI, o formulário curto do International Consultation on Incontinence Questionnaire (ICIQ-SF) e os questionários do Incontinence Severity Index (ISI). As mulheres foram classificadas em quatro grupos: magras normoglicêmicas, obesas normoglicêmicas, magras hiperglicêmicas e obesas hiperglicêmicas. As diferenças entre os grupos foram testadas por meio de estatística descritiva. As associações foram estimadas usando análise de regressão logística e apresentadas como odds ratio não ajustadas e ajustadas.

Resultados As taxas de prevalência de PSUI não foram diferentes entre os grupos. No entanto, houve diferença significativa nos grupos hiperglicêmicos com piores escores para PSUI grave e muito grave. Quando os dados ajustados para fatores de confusão foram comparados ao grupo magro normoglicêmico, o grupo obeso hiperglicêmico teve chances significativamente maiores de formas graves e muito graves de IU usando ICIQ-SF (aOR 3,157; IC 95% 1,308 a 7,263) e ISI (aOR 20,324; 95% CI 2,265 a 182,329) questionários e maior impacto percebido de PSUI (aOR 4,449; 95% CI 1,591 a 12,442).

Conclusão Nossos dados indicam que a obesidade e a hiperglicemia durante a gravidez aumentam significativamente as chances de formas graves e o impacto percebido da PSUI. Portanto, tratamentos preventivos e curativos mais eficazes são extremamente necessários.

Contributors

All authors were involved in the design and interpretation of the analyses, contributed to the writing of the manuscript, and read and approved the final manuscript.




Publication History

Received: 15 September 2022

Accepted: 17 April 2023

Article published online:
21 July 2023

© 2023. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011; 108 (07) 1132-1138 DOI: 10.1111/j.1464-410X.2010.09993.x. [published Online First: 2011/01/15]
  • 2 Ekelund P, Grimby A, Milsom I. Urinary incontinence. Social and financial costs high. BMJ 1993; 306: 1344 DOI: 10.1136/bmj.306.6888.1344. (6888): [published Online First: 1993/05/15]
  • 3 Markland AD, Richter HE, Fwu CW, Eggers P, Kusek JW. Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008. J Urol 2011; 186 (02) 589-593 DOI: 10.1016/j.juro.2011.03.114. [published Online First: 2011/06/21]
  • 4 Amaro JL, Macharelli CA, Yamamoto H, Kawano PR, Padovani CV, Agostinho AD. Prevalence and risk factors for urinary and fecal incontinence in Brazilian women. Int Braz J Urol 2009; 35 (05) 592-597 , discussion 598 DOI: 10.1590/s1677-55382009000500011. [published Online First: 2009/10/29]
  • 5 Liang CC, Chang SD, Lin SJ, Lin YJ. Lower urinary tract symptoms in primiparous women before and during pregnancy. Arch Gynecol Obstet 2012; 285 (05) 1205-1210 DOI: 10.1007/s00404-011-2124-2. [published Online First: 2011/11/02]
  • 6 Sangsawang B, Sangsawang N. Stress urinary incontinence in pregnant women: a review of prevalence, pathophysiology, and treatment. Int Urogynecol J Pelvic Floor Dysfunct 2013; 24 (06) 901-912 DOI: 10.1007/s00192-013-2061-7. [published Online First: 2013/02/26]
  • 7 Hvidman L, Hvidman L, Foldspang A, Mommsen S, Bugge Nielsen J. Correlates of urinary incontinence in pregnancy. Int Urogynecol J Pelvic Floor Dysfunct 2002; 13 (05) 278-283 DOI: 10.1007/s001920200061. [published Online First: 2002/10/02]
  • 8 Sangsawang B. Risk factors for the development of stress urinary incontinence during pregnancy in primigravidae: a review of the literature. Eur J Obstet Gynecol Reprod Biol 2014; 178: 27-34 DOI: 10.1016/j.ejogrb.2014.04.010. [published Online First: 2014/05/03]
  • 9 Chuang CM, Lin IF, Horng HC, Hsiao YH, Shyu IL, Chou P. The impact of gestational diabetes mellitus on postpartum urinary incontinence: a longitudinal cohort study on singleton pregnancies. BJOG 2012; 119 (11) 1334-1343 DOI: 10.1111/j.1471-0528.2012.03468.x. [published Online First: 2012/08/21]
  • 10 Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373: 1773-1779 DOI: 10.1016/S0140-6736(09)60731-5. (9677): [published Online First: 2009/05/26]
  • 11 Yun S, Kabeer NH, Zhu BP, Brownson RC. Modifiable risk factors for developing diabetes among women with previous gestational diabetes. Prev Chronic Dis 2007; 4 (01) A07 [published Online First: 2006/12/19]
  • 12 Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303 (03) 235-241 DOI: 10.1001/jama.2009.2014. [published Online First: 2010/01/15]
  • 13 Heslehurst N, Ells LJ, Simpson H, Batterham A, Wilkinson J, Summerbell CD. Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36,821 women over a 15-year period. BJOG 2007; 114 (02) 187-194 DOI: 10.1111/j.1471-0528.2006.01180.x. [published Online First: 2007/02/20]
  • 14 Thangaratinam S, Rogozińska E, Jolly K. et al. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technol Assess 2012; 16 (31) iii-iv, 1–191 DOI: 10.3310/hta16310. [published Online First: 2012/07/21]
  • 15 Waetjen LE, Liao S, Johnson WO. et al. Factors associated with prevalent and incident urinary incontinence in a cohort of midlife women: a longitudinal analysis of data: study of women's health across the nation. Am J Epidemiol 2007; 165 (03) 309-318 DOI: 10.1093/aje/kwk018. [published Online First: 2006/11/30]
  • 16 Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ 2017; 356: j1 DOI: 10.1136/bmj.j1. [published Online First: 20170208]
  • 17 Doumouchtsis SK, Loganathan J, Pergialiotis V. The role of obesity on urinary incontinence and anal incontinence in women: a review. BJOG 2022; 129 (01) 162-170 DOI: 10.1111/1471-0528.16848. [published Online First: 20210914]
  • 18 Nambiar AK, Arlandis S, Bø K. et al. European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence. Eur Urol 2022; 82 (01) 49-59 DOI: 10.1016/j.eururo.2022.01.045. [published Online First: 2022/02/27]
  • 19 Abrams P, Cardozo L, Wagg A. , et al. 6th International Consultation on Incontinence2017.
  • 20 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37: S81-S90 DOI: 10.2337/dc14-S081. (Suppl 1): [published Online First: 2013/12/21]
  • 21 Rudge MVC, Barbosa AMP, Sobrevia L. et al; Perinatal Diabetes Research Group. Altered maternal metabolism during mild gestational hyperglycemia as a predictor of adverse perinatal outcomes: A comprehensive analysis. Biochim Biophys Acta Mol Basis Dis 2020; 1866 (02) 165478 DOI: 10.1016/j.bbadis.2019.05.014. [published Online First: 2019/06/04]
  • 22 Rudge MV, Calderon IM, Ramos MD, Abbade JF, Rugolo LM. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis. Gynecol Obstet Invest 2000; 50 (02) 108-112 DOI: 10.1159/000010293. [published Online First: 2000/08/31]
  • 23 WHO Consultation on Obesity. ( 1999: Geneva SWHO. Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization; 2000
  • 24 Pereira VS, Santos JY, Correia GN, Driusso P. [Translation and validation into Portuguese of a questionnaire to evaluate the severity of urinary incontinence]. Rev Bras Ginecol Obstet 2011; 33 (04) 182-187 DOI: 10.1590/s0100-72032011000400006. [published Online First: 2011/08/17]
  • 25 Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health 1993; 47 (06) 497-499 DOI: 10.1136/jech.47.6.497. [published Online First: 1993/12/01]
  • 26 Tamanini JT, Dambros M, D'Ancona CA, Palma PC, Rodrigues Netto Jr N. [Validation of the “International Consultation on Incontinence Questionnaire -- Short Form” (ICIQ-SF) for Portuguese]. Rev Saude Publica 2004; 38 (03) 438-444 DOI: 10.1590/s0034-89102004000300015. [published Online First: 2004/07/10]
  • 27 Haylen BT, de Ridder D, Freeman RM. et al; International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29 (01) 4-20 DOI: 10.1002/nau.20798. [published Online First: 2009/11/27]
  • 28 Liang CC, Chao M, Chang SD, Chiu SY. Impact of prepregnancy body mass index on pregnancy outcomes, incidence of urinary incontinence and quality of life during pregnancy - An observational cohort study. Biomed J 2020; 43 (06) 476-483 DOI: 10.1016/j.bj.2019.11.001. [published Online First: 20201124]
  • 29 Lao TT, Ho LF, Chan BC, Leung WC. Maternal age and prevalence of gestational diabetes mellitus. Diabetes Care 2006; 29 (04) 948-949 DOI: 10.2337/diacare.29.04.06.dc05-2568. [published Online First: 2006/03/29]
  • 30 Casagrande SS, Linder B, Cowie CC. Prevalence of gestational diabetes and subsequent Type 2 diabetes among U.S. women. Diabetes Res Clin Pract 2018; 141: 200-208 DOI: 10.1016/j.diabres.2018.05.010. [published Online First: 2018/05/18]
  • 31 Sibai BM, Ross MG. Hypertension in gestational diabetes mellitus: pathophysiology and long-term consequences. J Matern Fetal Neonatal Med 2010; 23 (03) 229-233 DOI: 10.3109/14767050903550899. [published Online First: 2010/02/04]
  • 32 Dinç A. Prevalence of Urinary Incontinence During Pregnancy and Associated Risk Factors. Low Urin Tract Symptoms 2018; 10 (03) 303-307 DOI: 10.1111/luts.12182. [published Online First: 2017/07/05]
  • 33 Daly D, Clarke M, Begley C. Urinary incontinence in nulliparous women before and during pregnancy: prevalence, incidence, type, and risk factors. Int Urogynecol J Pelvic Floor Dysfunct 2018; 29 (03) 353-362 DOI: 10.1007/s00192-018-3554-1. [published Online First: 2018/01/25]
  • 34 Brown SJ, Donath S, MacArthur C, McDonald EA, Krastev AH. Urinary incontinence in nulliparous women before and during pregnancy: prevalence, incidence, and associated risk factors. Int Urogynecol J Pelvic Floor Dysfunct 2010; 21 (02) 193-202 DOI: 10.1007/s00192-009-1011-x. [published Online First: 2009/10/17]
  • 35 Viktrup L. The risk of lower urinary tract symptoms five years after the first delivery. Neurourol Urodyn 2002; 21 (01) 2-29 DOI: 10.1002/nau.2198. [published Online First: 2002/02/09]
  • 36 Dolan LM, Walsh D, Hamilton S, Marshall K, Thompson K, Ashe RG. A study of quality of life in primigravidae with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15 (03) 160-164 DOI: 10.1007/s00192-004-1128-x. [published Online First: 2004/05/29]
  • 37 van de Pol G, van Brummen HJ, Bruinse HW, Heintz AP, van der Vaart CH. Is there an association between depressive and urinary symptoms during and after pregnancy?. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18 (12) 1409-1415 DOI: 10.1007/s00192-007-0371-3. [published Online First: 2007/04/04]
  • 38 Piculo F, Marini G, Vesentini G. et al. Pregnancy-specific urinary incontinence in women with gestational hyperglycaemia worsens the occurrence and severity of urinary incontinence and quality of life over the first year post partum. Eur J Obstet Gynecol Reprod Biol 2020; 252: 336-343 DOI: 10.1016/j.ejogrb.2020.06.036. [published Online First: 2020/07/14]
  • 39 Zhu L, Li L, Lang JH, Xu T. Prevalence and risk factors for peri- and postpartum urinary incontinence in primiparous women in China: a prospective longitudinal study. Int Urogynecol J Pelvic Floor Dysfunct 2012; 23 (05) 563-572 DOI: 10.1007/s00192-011-1640-8. [published Online First: 2012/01/27]
  • 40 Lamerton TJ, Torquati L, Brown WJ. Overweight and obesity as major, modifiable risk factors for urinary incontinence in young to mid-aged women: a systematic review and meta-analysis. Obes Rev 2018; 19 (12) 1735-1745 DOI: 10.1111/obr.12756. [published Online First: 2018/09/20]
  • 41 Danforth KN, Townsend MK, Lifford K, Curhan GC, Resnick NM, Grodstein F. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol 2006; 194 (02) 339-345 DOI: 10.1016/j.ajog.2005.07.051. [published Online First: 2006/02/07]
  • 42 Eltatawy HH, Eltatawy TM, Soliman MG. et al. The link between female obesity and urinary stress incontinence. Uro Today Int J 2011; 4 (05) x
  • 43 Noblett KL, Jensen JK, Ostergard DR. The relationship of body mass index to intra-abdominal pressure as measured by multichannel cystometry. Int Urogynecol J Pelvic Floor Dysfunct 1997; 8 (06) 323-326 DOI: 10.1007/BF02765589. [published Online First: 1997/01/01]
  • 44 Kim C, McEwen LN, Sarma AV, Piette JD, Herman WH. Stress urinary incontinence in women with a history of gestational diabetes mellitus. J Womens Health (Larchmt) 2008; 17 (05) 783-792 DOI: 10.1089/jwh.2007.0616. [published Online First: 2008/06/10]
  • 45 Barbosa AM, Dias A, Marini G, Calderon IM, Witkin S, Rudge MV. Urinary incontinence and vaginal squeeze pressure two years post-cesarean delivery in primiparous women with previous gestational diabetes mellitus. Clinics (São Paulo) 2011; 66 (08) 1341-1346 DOI: 10.1590/s1807-59322011000800006. [published Online First: 2011/09/15]
  • 46 Vesentini G, Barbosa AMP, Damasceno DC. et al; DIAMATER Study Group. Alterations in the structural characteristics of rectus abdominis muscles caused by diabetes and pregnancy: A comparative study of the rat model and women. PLoS One 2020; 15 (04) e0231096 DOI: 10.1371/journal.pone.0231096. [published Online First: 2020/04/04]
  • 47 Vesentini G, Barbosa AMP, Floriano JF. et al; Diamater Study Group. Deleterious effects of gestational diabetes mellitus on the characteristics of the rectus abdominis muscle associated with pregnancy-specific urinary incontinence. Diabetes Res Clin Pract 2020; 166: 108315 DOI: 10.1016/j.diabres.2020.108315. [published Online First: 2020/07/18]
  • 48 Diaz D, Robinson D, Bosch R. , et al. Patient-reported outcome assessment. In: Abrams P, Cardozo L, Wagg A, et al., eds. 6th International Consultation on Incontinence: ICI–ICS. International Continence Society, Bristol UK 2017:541–98.